TELA (TELA Bio) Total Debt to Capital
Market price action on GURU.Markets for the total debt-to-equity ratio of TELA Bio, Inc. (TELA) stands at 0.00, accompanying a period of intensive bioprosthesis implementation and the expansion of sales channels in the US. The business relies on the supply of hybrid meshes for hernia repair to clinics, while production processes are optimized through the use of third-party plants and external logistics.
%20-%20All%20Debt%20to%20Shareholders'%20Equity%20Ratio&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_TELA_-_TELA-Bio-Inc._-_All-Debt-to-Shareholders-Equity-Ratio "TELA (telabio.com) Total Debt to Capital history from 07/04/2022 to 10/30/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns and data insights for company TELA Bio (TELA)
This indicator measures financial leverage by comparing total credit obligations against net assets to assess the business's degree of dependence on borrowed capital. Analyzing the total debt-to-equity ratio allows investors to evaluate the solvency of TELA Bio, Inc. (TELA) during the commercialization phase of the OviTex product line, where the stability of the technological cycle requires minimizing debt risks to preserve share value.